Mainz Biomed has announced the initiation of eAArly DETECT, its US extension of ColoFuture, which is the Company’s European feasibility study evaluating the integration of a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert.

Leica Microsystems and Cell Signaling Technology (CST) have announced a partnership to validate CST antibodies on the Cell DIVE multiplexed imaging solution.

OncoHost has developed a novel predictive model for clinical benefit of immune checkpoint inhibitor in non-small cell lung cancer patients.

This year, the Biochemical Analytics Prize, endowed with 50,000 euros, will be
awarded to biochemistry professor, Dr Kai Simons and analytical chemist, Dr
Andrej Shevchenko, as well as to Professor Andreas Greinacher, a transfusion
medicine physician.

AMSBIO announces RNAdvantage – the first product in a new range of stabilization solutions that provide robust protection for your RNA samples at ambient temperature.

The SQUEEZE project planned to start early 2023 will discover new ways to maximize the impact of prescription drugs for patients suffering from the chronic autoimmune disease Rheumatoid Arthritis.

The Dynabeads™ Streptavidin for in vitro transcription and Dynabeads Carboxylic Acid for RNA purification solutions support scalable GMP-grade synthesis and purification of mRNA for vaccine development and manufacturing.

Harley Street Medical Area Healthcare Conference taking place on Wednesday 19th October 2022 is bringing together an impressive panel of speakers from some of London’s world-leading institutions to discuss global trends in the life sciences sector, and how the city is driving and responding to those trends.

Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group.

PhoreMost Ltd. today announced it has entered into a multi-project target discovery collaboration with Roche.